Skip to main content

IMI - RT Cure

IMI - Rheuma Tolerance for Cure (RT Cure)

The project “Rheuma Tolerance for Cure “ (RTCure) is a follow-on project of BTCure and funded by the Innovative Medicine Initiative (IMI), a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The main objective of the project is to prevent and treat rheumatoid arthritis or its progression by inhibiting maturation/expansion of pathogenic autoimmune responses through immune tolerising treatments of subjects not only in early stages of joint inflammation but also in even earlier defined stages i.e. before onset of joint inflammation, when patients have arthralgia and/or bone loss, or sub-clinical stages of joint inflammation. In addition, tools for monitoring immune tolerance will be developed.

Contact: Prof. Dr. med. Georg Schett